Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Restructuring Costs: 2013-2020

Historic Restructuring Costs for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Dec 2020 value amounting to $3.3 million.

  • Avadel Pharmaceuticals' Restructuring Costs fell 103.70% to -$69,000 in Q3 2020 from the same period last year, while for Sep 2020 it was -$428,000, marking a year-over-year decrease of 126.46%. This contributed to the annual value of $3.3 million for FY2020, which is 293.73% up from last year.
  • According to the latest figures from FY2020, Avadel Pharmaceuticals' Restructuring Costs is $3.3 million, which was up 293.73% from $845,000 recorded in FY2019.
  • In the past 5 years, Avadel Pharmaceuticals' Restructuring Costs ranged from a high of $49.3 million in FY2016 and a low of -$31.0 million during FY2017.
  • Over the past 3 years, Avadel Pharmaceuticals' median Restructuring Costs value was $845,000 (recorded in 2019), while the average stood at -$6.2 million.
  • Its Restructuring Costs has fluctuated over the past 5 years, first plummeted by 162.98% in 2017, then soared by 293.73% in 2020.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Restructuring Costs stood at $49.3 million in 2016, then slumped by 162.98% to -$31.0 million in 2017, then rose by 26.77% to -$22.7 million in 2018, then surged by 103.72% to $845,000 in 2019, then surged by 293.73% to $3.3 million in 2020.